Weiss Multi Strategy Advisers LLC Applied Genetic Technologies Corp Transaction History

Weiss Multi Strategy Advisers LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.07 - $2.71 $11,349 - $28,744	-10,607 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.87 - $2.91 $80 - $125	-43 Reduced 0.4%	10,607 $20,000
Q3 2021 Nov 15, 2021	BUY	$3.01 - $4.12 $695 - $951	231 Added 2.22%	10,650 $32,000
Q2 2021 Aug 16, 2021	BUY	$3.62 - $5.23 $1,353 - $1,956	374 Added 3.72%	10,419 $41,000
Q1 2021 May 14, 2021	SELL	$3.94 - $8.19 $26,571 - $55,233	-6,744 Reduced 40.17%	10,045 $51,000
Q4 2020 Feb 16, 2021	SELL	$3.99 - $5.7 $5,633 - $8,048	-1,412 Reduced 7.76%	16,789 $69,000
Q3 2020 Nov 16, 2020	BUY	$4.38 - $6.43 $880 - $1,292	201 Added 1.12%	18,201 $88,000
Q2 2020 Aug 14, 2020	BUY	$3.0 - $6.9 $7,668 - $17,636	2,556 Added 16.55%	18,000 $100,000
Q1 2020 May 15, 2020	SELL	$2.36 - $9.86 $1,312 - $5,482	-556 Reduced 3.48%	15,444 $51,000
Q4 2019 Feb 14, 2020	BUY	$2.69 - $4.92 $2,690 - $4,920	1,000 Added 6.67%	16,000 $72,000
Q3 2019 Nov 14, 2019	BUY	$2.59 - $4.16 $38,850 - $62,400	15,000 New	15,000 $62,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.